GENB: the cash flow

MyFinsight

For the quarter ending 2026-03-31, GENB had $38,569K increase in cash & cash equivalents over the period. -$84,169K in free cash flow.

Cash Flow	2026-03-31
Net loss	-61,714
Amortization and accretion on marketable securities	146
Non-cash stock-based compensation	6,395
Non-cash lease expense	2,094
Depreciation and amortization	3,273
Changes in fair value of convertible preferred stock warrant liability	363
Accounts receivable	0
Prepaid expenses and other current assets	6,221
Other assets	-2,045
Accounts payable	3,754
Operating lease liabilities	-1,841
Other long term liabilities	-117
Accrued expenses and other liabilities	-21,049
Deferred revenue	-7,224
Net cash used in operating activities	-80,388
Purchase of marketable securities	321,153
Purchases of property and equipment	3,781
Proceeds from sales and maturities of marketable securities	65,000
Net cash used in investing activities	-259,934
Proceeds from issuance of convertible preferred stock, net of issuance costs	0
Proceeds from issuance of common stock from the initial public offering, net of underwriting discounts, commissions and offering expenses	369,289
Contributions from non-controlling interests	7,500
Proceeds from exercise of stock options	3,217
Payments on finance lease obligations	1,115
Net cash provided by financing activities	378,891
Net increase (decrease) in cash, cash equivalents and restricted cash	38,569
Cash, cash equivalents and restricted cash at beginning of period	126,038
Cash, cash equivalents and restricted cash at end of period	164,607

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.